Subscribe

INFECTIOUS DISEASE IVD MARKET

INFECTIOUS DISEASE IVD MARKET REVIEW

Published July 2024 - 356 pages

There is no more stable growing sector of in vitro diagnostics than infectious disease testing. 

That’s because new threats, improved devices, and the increased global funding of new testing all point towards a reliable increase in revenues for infectious disease IVD companies.  It’s also a market that has shown it can support a large base of companies, including new entrants.

To guide you though this market opportunity, trust the brand that provides the news coverage that you trust. EYE ON IVD’S INFECTIOUS DISEASE IVD MARKET REVIEW REPORT, developed by analysts with two decades of experience in the market, provides a superior quality reference tool for business planning and forecasting, market assessment and product management. 

Those who follow EYE ON IVD newsletter’s cutting analysis will know this is resource as a thorough market review designed by IVD industry experts, not a report by a market research compiler that produces thousands of reports.  The report reveals over a dozen infectious disease areas that beat growth in the IVD market, including some testing areas that are doubling or tripling the revenue growth of the market. 

Disease Markets Estimated and Forecasted in this comprehensive report include:

HIV (Molecular and Immunoassay), 2019 to 2035

Hepatitis (By Type), 2019 to 2035

STIs (Chlamydia, HPV, Gonorrhea, Trichomoniasis, HSV, Syphilis), 2019 to 2035

HAIs (C. diff., Sepsis, MRSA, VRE, Other), 2019 to 2035

Respiratory (RSV, Influenza, COVID, Others), 2019 to 2035

TORCH Testing (POC and Lab-based), 2019 to 2035

ID/AST Testing (Automated/Manual), 2019 to 2035

Non-Lyme Parasitic Infections, 2019 to 2035

  • Gastrointestinal Infections,  2019 to 2035

Fungal Infections,  2019 to 2035

Tuberculosis,  2019 to 2035 

Malaria,  2019 to 2035

Other Infectious Diseases (West Nile, Chagas, Dengue, Zika, Marburg, Ebola, Other Emerging), 2019 to 2035

The report analyzes trends, such as the drop in COVID revenues, and how IVDs are doing replacing that revenue.  It looks at the current state of the China IVD market, and how infectious disease scares are creating opportunity for large concerns.  The report also profiles top companies in the market, and looks at with 20 disease areas and 21 country and regions market, the report offers exceptional coverage.
 
IVD is a global market, and this superior report reflects that the international market may offer different opportunities than the United States or European markets. Country market are estimated from 2018 to 2031. (reflecting greater possibility of forecast change and country developments).
 
Country and Region Markets Include:
 

United States
Canada
Mexico
UK
Germany
France
Spain
Italy
Eastern Europe
Latin America
Middle East and Africa
China
Japan
South Korea
Saudi Arabia

(For each country/region – the report breaks out: Respiratory, STIs, HAIs, ID/AST, Hepatitis, AIDS/HIV, Influenza, Tuberculosis, TORCH, Other)

 There are many approaches to testing for infectious disease, each with its own markets and sub markets.  This report breaks out markets by type of product to accomodate this level of business planning, including Panel vs. non-Panel, molecular and immunoassay, POC/Lab.   Also included in the report is a breakout of competition.


Companies in the Market w/ Recent Developments and 2023 Revenues
Companies to Watch, w/ important innovations and milestones.


 

REQUEST SAMPLE PAGES

Sample Page Request

Have a Question?

If you have questions about our report product, please contact Eye On IVD below.

Contact Form Demo

Exit mobile version